Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kallyope
Biotech
Bayer taps new chief medical officer—Chutes & Ladders
Bayer taps new chief medical officer. Cantor steps into PhRMA’s house as CEO. Moderna veteran rejoins for second act.
Darren Incorvaia
,
Marissa Russo
,
Donavyn Coffey
,
James Waldron
Oct 2, 2026 8:30am
Novo corrals 3 new early-stage obesity drugs from Kallyope
Sep 18, 2026 11:23am
Kallyope links oral obesity combo to 3% weight loss at Week 13
Feb 27, 2025 10:17am
Biotech's top money raisers: 2022
Apr 11, 2023 9:19am
Catalent shakes up leadership, taps new CEO—Chutes & Ladders
Jul 8, 2022 9:30am
New report surveys declining biopharma deal activity in Q1
Jun 9, 2022 4:56am